BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28107203)

  • 1. Clinicopathological significance of intratumoral and peritumoral lymphocytes and lymphocyte score based on the histologic subtypes of cutaneous melanoma.
    Park CK; Kim SK
    Oncotarget; 2017 Feb; 8(9):14759-14769. PubMed ID: 28107203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological significance of tumor-infiltrating lymphocytes and programmed death-1 expression in cutaneous melanoma: a comparative study on clinical subtypes.
    Lee WJ; Lee YJ; Shin HJ; Won CH; Chang SE; Choi JH; Lee MW
    Melanoma Res; 2018 Oct; 28(5):423-434. PubMed ID: 29634635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
    Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
    J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
    Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
    Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of B-cell density in cutaneous melanoma.
    Ladányi A; Kiss J; Mohos A; Somlai B; Liszkay G; Gilde K; Fejös Z; Gaudi I; Dobos J; Tímár J
    Cancer Immunol Immunother; 2011 Dec; 60(12):1729-38. PubMed ID: 21779876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.
    Castaneda CA; Torres-Cabala C; Castillo M; Villegas V; Casavilca S; Cano L; Sanchez J; Dunstan J; Calderon G; De La Cruz M; Cotrina JM; Gomez HL; Galvez R; Abugattas J
    Clin Transl Oncol; 2017 Dec; 19(12):1478-1488. PubMed ID: 28577153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
    Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
    J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma.
    Lynch KT; Young SJ; Meneveau MO; Wages NA; Engelhard VH; Slingluff CL; Mauldin IS
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34103353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
    Ladányi A; Kiss J; Somlai B; Gilde K; Fejos Z; Mohos A; Gaudi I; Tímár J
    Cancer Immunol Immunother; 2007 Sep; 56(9):1459-69. PubMed ID: 17279413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
    Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
    Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
    Špirić Z; Eri Ž; Erić M
    Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-interleukin-2 scintigraphy as a potential tool for evaluating tumor-infiltrating lymphocytes in melanoma lesions: a validation study.
    Signore A; Annovazzi A; Barone R; Bonanno E; D'Alessandria C; Chianelli M; Mather SJ; Bottoni U; Panetta C; Innocenzi D; Scopinaro F; Calvieri S
    J Nucl Med; 2004 Oct; 45(10):1647-52. PubMed ID: 15471828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
    Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
    Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma.
    Ladányi A; Somlai B; Gilde K; Fejös Z; Gaudi I; Tímár J
    Clin Cancer Res; 2004 Jan; 10(2):521-30. PubMed ID: 14760073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theragnostic significance of tumor-infiltrating lymphocytes and Ki67 in BRAFV600-mutant metastatic melanoma (BRIM-3 trial).
    Googe PB; Theocharis S; Pergaris A; Li H; Yan Y; McKenna EF; Moschos SJ
    Curr Probl Cancer; 2022 Jun; 46(3):100862. PubMed ID: 35398635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thin cutaneous malignant melanomas (< or =1.5 mm): identification of risk factors indicative of progression.
    Massi D; Franchi A; Borgognoni L; Reali UM; Santucci M
    Cancer; 1999 Mar; 85(5):1067-76. PubMed ID: 10091790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of lymphocyte-activating gene 3 and T-cell immunoreceptor with immunoglobulin and ITIM domains in cutaneous melanoma and their correlation with programmed cell death 1 expression in tumor-infiltrating lymphocytes.
    Lee WJ; Lee YJ; Choi ME; Yun KA; Won CH; Lee MW; Choi JH; Chang SE
    J Am Acad Dermatol; 2019 Jul; 81(1):219-227. PubMed ID: 30880064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
    J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.
    Fortes C; Mastroeni S; Mannooranparampil TJ; Passarelli F; Zappalà A; Annessi G; Marino C; Caggiati A; Russo N; Michelozzi P
    Melanoma Res; 2015 Aug; 25(4):306-11. PubMed ID: 25933208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of histological regression as a prognostic factor in cutaneous melanoma patients.
    Tas F; Erturk K
    Melanoma Res; 2016 Oct; 26(5):492-6. PubMed ID: 27380112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.